Sudeep Pharma Ltd (SUDEEPPHRM) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

68.05 k (-24.42%) Volume

Shareholding (Dec 2025)

FII

1.67%

Held by 13 FIIs

DII

10.86%

Held by 11 DIIs

Promoter

76.15%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 6,858 Cr ()

P/E

50.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.00

Return on Equity

0.00%

Price to Book

9.27

Revenue and Profits:

Net Sales:

163 Cr

(Quarterly Results - Sep 2025)

Net Profit:

46 Cr

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Board Meeting Intimation for Approval Of Unaudited Financial Results As On 31St December 2025 Along With Other Business Items

02-Feb-2026 | Source : BSE

Sudeep Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and Nine Months ended on 31st December 2025 along with other business items.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

02-Feb-2026 | Source : BSE

This is to inform that the Earnings Call of the Company with Analysts/Investors to discuss the operational & financial performance for the quarter and nine ended on December 31 2025 is scheduled as below: Day & Date: Monday 09th February 2026 Time: 11:30 a.m. IST Registration Link and Access numbers: As per Annexure

Announcement Under Regulation 30 (LODR) - Intimation Of Approval For Purchase Of Rights In Leasehold Land In GIDC By Sudeep Advanced Materials Private Limited A Wholly Owned Subsidiary (WOS) Of The Company.

22-Jan-2026 | Source : BSE

We hereby inform you that the Companys Wholly Owned Subsidiary i.e. Sudeep Advanced Materials Private Limited has purchased the rights in leasehold land in Dahej Gujarat (GIDC) from DCM Shriram Fine Chemicals Limited.

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

37.35

Debt to EBITDA (avg)

0.74

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.60

Tax Ratio

24.13%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

19.27%

ROCE (avg)

23.00%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

9.49

EV to EBIT

38.75

EV to EBITDA

36.59

EV to Capital Employed

8.69

EV to Sales

13.85

PEG Ratio

Dividend Yield

ROCE (Latest)

22.44%

ROE (Latest)

19.15%

Technicals key factors

Indicator

Weekly

Monthly

No records

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 13 Schemes (5.67%)

FIIs

Held by 13 FIIs (1.67%)

Promoter with highest holding

Riva Resources Private Limited (40.35%)

Highest Public shareholder

Nuvama Crossover Opportunities Fund - Series Iii (3.42%)

Individual Investors Holdings

3.27%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 9.62% vs -24.58% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 18.02% vs -14.43% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "87.88",
          "val2": "80.17",
          "chgp": "9.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.87",
          "val2": "30.39",
          "chgp": "1.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.03",
          "val2": "1.44",
          "chgp": "40.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "29.74",
          "val2": "25.20",
          "chgp": "18.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.13%",
          "val2": "37.91%",
          "chgp": "-2.78%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Sudeep Pharma"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Sudeep Pharma"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "356.73",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "131.96",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "4.81",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "95.75",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.99%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

87.88

80.17

9.62%

Operating Profit (PBDIT) excl Other Income

30.87

30.39

1.58%

Interest

2.03

1.44

40.97%

Exceptional Items

0.00

Standalone Net Profit

29.74

25.20

18.02%

Operating Profit Margin (Excl OI)

35.13%

37.91%

-2.78%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 9.62% vs -24.58% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 18.02% vs -14.43% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Change(%)

Net Sales

356.73

Operating Profit (PBDIT) excl Other Income

131.96

Interest

4.81

Exceptional Items

0.00

Standalone Net Profit

95.75

Operating Profit Margin (Excl OI)

36.99%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About

Company Coordinates

Company Details

Tel:

Registrar Details

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support@mojoinfinity.com, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."